May 29, 2020
Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint(TM)
May 29, 2020
Agendia Announces Data Presented at ASCO 2020 Demonstrating Importance of Further Classification of Breast Cancers to Enable Precise Prognosis and Treatment
May 18, 2020
Global Biochips Market Report 2020: Historic Analysis and Projections through 2018-2028
May 07, 2020
Agendia Co-Founder and Chief Scientific Officer René Bernards, PhD Elected to the National Academy of Sciences
May 06, 2020
LetsGetChecked Closes Oversubscribed $71 Million Series C Funding Round to Fuel Rapid US Expansion
Apr 27, 2020
I-SPY2 TRIAL Demonstrates Significant Improvement in pCR with Durvalumab and Olaparib with Paclitaxel, (Compared to Chemotherapy Alone) in Women with Stage II/III High-Risk, HER2-Negative Breast Cancer, in HR+ and TNBC Subsets
Apr 16, 2020
Long Term Analytical Validation Study Further Confirms BluePrint as a Reliable Genomic Profiling Assay for Early Stage Breast Cancer Patients
Mar 30, 2020
Global Biochips Market Analysis and Forecast Report 2020 - DNA Chips Segment Shows Potential to Grow Over 18.9%
Mar 26, 2020
The single cell sequencing industry analysis projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029
Mar 04, 2020
Genomics Market Size Worth $31.1 Billion by 2027 | CAGR: 7.7%: Grand View Research, Inc.
Feb 21, 2020
Molecular Cancer Diagnostics Market Insights, 2019 to 2025 - Industry Developments, Technologies, Products, Regions, and Competitors
Feb 17, 2020
DNA Sequencing Market to Reach $25.47 Billion by 2025: AMR
Jan 22, 2020
Zymergen Appoints Jay Flatley and Sandra E. Peterson to the Board of Directors
Jan 17, 2020
Laura van 't Veer, PhD, Co-Inventor of MammaPrint, Honored with the PMWC Luminary Award at Precision Medicine World Conference 2020
Jan 10, 2020
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests
Jan 03, 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint® Testing through Techniker Krankenkasse
Dec 12, 2019
New Data Compare Genomic Profiling Results for Premenopausal Women with Early-Stage Breast Cancer
Dec 02, 2019
Next-generation Sequencing (NGS) Market Worth $24.4 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Nov 19, 2019
Agendia to Present New Data at SABCS 2019 Demonstrating How Comprehensive Genomic Profiling Benefits Early-Stage Breast Cancer Patients
Nov 12, 2019
United States Non-Invasive Prenatal Testing Market to 2027 Featuring Major Players - Natera, Illumina, Laboratory Corporation of America Holdings